Immunohistochemical Detection of HER1/HER2 Can Be Considered a Predictive Marker of Gefitinib Activity in Non-Small-Cell Lung Cancer?
2005 ◽
Vol 23
(4)
◽
pp. 921-922
◽
Keyword(s):
Keyword(s):
Keyword(s):
2009 ◽
Vol 4
(9)
◽
pp. 1066-1074
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 14
(6)
◽
pp. 963-967
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):